Nuvectis Pharma, Inc. (NVCT) NASDAQ
8.70
-0.12(-1.36%)
Currency In USD
- General
- Statistics
- Historical Data
- Profile
- Financials
Valuation
| Market Cap | 164.69M |
| Enterprise Value | 133.05M |
| P/E Ratio | -7.18 |
| PEG Ratio | 0.36 |
| Price/Sales Ratio | 0 |
| Price/Book Ratio | 10.31 |
| Enterprise/Revenue | 0 |
| Enterprise/EBITDA | -7.21 |
Fiscal Year
| Fiscal Year | December 31, 2025 |
| Most Recent Quarter | December 31, 2025 |
Profitability
| Profit Margin | 0 |
| Operating Margin | 0 |
Management Effectiveness
| Return On Assets | -0.83 |
| Return On Equity | -1.32 |
Income Statement
| Revenue | 0 |
| Revenue/Share | 0 |
| Gross Profit | 0 |
| EBITDA | -27.57M |
| Net Income | -26.44M |
| Diluted EPS | -1.32 |
Balance Sheet
| Total Cash | 31.63M |
| Total Cash/Share | 1.45 |
| Total Debt | 0 |
| Total Debt/Equity | 0 |
| Current Ratio | 2.38 |
| Book Value Per Share | 0.84 |
Price History
| 52-Week Change | -16.43 |
| 52-Week High | 11.52 |
| 52-Week Low | 5.55 |
| Moving Average 50 Days | 8.51 |
| Moving Average 200 Days | 7.37 |
Statistics
| Average Volume | 57,883 |
| Shares Outstanding | 26.49M |
| % Held by Institutions | 18.66 |
Dividend And Splits
| Trailing Annual Dividend Rate | 0 |
| Trailing Annual Dividend Yield | 0 |
| Payout Ratio | 0 |
| Last Split Factor | N/A |
| Last Split Date | N/A |
